Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amgen Inc (NASDAQ:AMGN)

166.81
Delayed Data
As of Sep 30
 +1.36 / +0.82%
Today’s Change
135.64
Today|||52-Week Range
176.85
+2.76%
Year-to-Date
Buy These 4 Stocks and Beat Biotech's Slump
Sep 30 / TheStreet.com - Paid Partner Content
Why Arrowhead Pharmaceuticals Stock Spiked Today
Sep 29 / MotleyFool.com - Paid Partner Content
Stock Market News for September 30, 2016
Sep 30 / Zacks.com - Paid Partner Content
7 Healthcare Stocks in Focus on World Heart Day
Sep 29 / Zacks.com - Paid Partner Content
Amgen (AMGN) Migraine Drug Hits Phase III Primary Endpoint
Sep 30 / Zacks.com - Paid Partner Content
FDA Approval of Amjevita Need Not Worry AbbVie Shareholders
Sep 28 / GuruFocus News - Paid Partner Content
Is It Too Late to Get In on This Millionaire-Maker Stock?
Sep 30 / MotleyFool.com - Paid Partner Content
Third Value Fund Avenue Buys 3 Stocks in 3rd Quarter
Sep 28 / GuruFocus News - Paid Partner Content
Allergan Focus on Brands, Biosimilar Products & Acquisitions
Sep 30 / Zacks.com - Paid Partner Content
Momenta to Regain Rights to Humira Biosimilar from Shire
Sep 28 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close165.45
Today’s open166.38
Day’s range165.27 - 167.72
Volume3,999,620
Average volume (3 months)2,856,354
Market cap$123.8B
Dividend yield2.40%
Data as of 4:14pm ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)+35.22%
Earnings growth (this year)+9.39%
Earnings growth (next 5 years)+8.30%
Revenue growth (last year)+6.49%
P/E ratio17.1
Price/Sales5.83
Price/Book4.44

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences+1.26+1.62%
BIIBBiogen+7.25+2.37%
ILMNIllumina Inc+5.10+2.89%
NBIXNeurocrine Bioscienc...+0.31+0.62%
Data as of 4:14pm ET, 09/30/2016

Financials

Next reporting dateOctober 18, 2016
EPS forecast (this quarter)$2.80
Annual revenue (last year)$21.3B
Annual profit (last year)$6.9B
Net profit margin32.52%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Esteban Santos
Corporate headquarters
Thousand Oaks, California

Forecasts

Search for Jobs